Millennium Management’s Transition Therapeutics TTHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-35,000
Closed -$239K – 4274
2015
Q1
$239K Buy
+35,000
New +$242K ﹤0.01% 3197

Other funds holding TTHI

Millennium Management's TTHI Position: Q2 2015 in Review

Millennium Management sold out of Transition Therapeutics (TTHI) in Q2 2015, closing a stake of 35,000 shares — an estimated $239K sold.

Millennium Management first reported a position in TTHI in Q1 2015 and held it in 1 quarter. The position peaked at $239K in Q1 2015. 30 funds tracked by Wall St. Rank hold TTHI as of Q2 2015.

  • Millennium Management reported no remaining Transition Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Millennium Management sold 35,000 Transition Therapeutics shares in Q2 2015, an estimated $239K.
  • Millennium Management first reported a position in Transition Therapeutics in Q1 2015 and held it in 1 quarter.
  • Millennium Management's Transition Therapeutics position peaked at $239K in Q1 2015.
  • 30 funds tracked by Wall St. Rank held Transition Therapeutics as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.